SCHOTT Builds Second Melting Tank for Pharmaceutical Glass Tubing in Mainz
Monday, January 11, 2021 , Mainz , Germany
- The international specialty glass manufacturer SCHOTT is building a second melting tank for pharmaceutical glass tubing at its main plant in Mainz, Germany. The investment volume amounts to 40 million euros.
- The new production facility is scheduled to go into operation in mid-2022 and will then offer 100 new jobs, 50 of which will be directly at SCHOTT. With this investment, SCHOTT is responding to the dynamically increasing global demand for glass tubing for pharmaceutical packaging.
"We decided in favor of the Mainz site in order to further strengthen our production base for pharmaceutical glass tubing in Germany and Europe. In doing so, we naturally also have our sights set on the manufacturers of COVID-19 pandemic vaccines based here and the European pharmaceutical industry as a whole," explained Dr. Frank Heinricht, Chairman of the Board of Management of SCHOTT AG. Due to the importance of this capacity expansion for the health care system in Germany and Europe, SCHOTT is exploring possible support with subsidies in talks with the regional government of Rhineland-Palatinate, the federal government of Germany and the European Union.
A significant expansion in pharmaceutical glass production
The pharmaceutical glass production in Mainz is part of a global production network of the Tubing Business Unit, which also includes the Mitterteich site in Germany as well as factories in Brazil, India and China. SCHOTT has already significantly expanded its production capacities for pharmaceutical tubing in Asia in the fall of 2020 with the commissioning of another tank in India and a completely new plant in China.
FIOLAX® pharmaceutical glass tubing from SCHOTT meets the highest quality standards in the pharmaceutical industry and is considered the gold standard for packaging medications. The borosilicate glass prevents interaction between the glass packaging and the medication, thus preserving the effectiveness of the medication. SCHOTT itself and its customers in the pharmaceutical packaging industry manufacture billions of vials, ampoules, syringes and cartridges from this special glass. Right now, SCHOTT's pharmaceutical vials are playing a special role in the fight against the Corona pandemic because the vaccines are being filled in them.
SCHOTT is a leading international technology group in the areas of specialty glass, glass-ceramics and related high-tech materials. With over 130 years of experience, the company is an innovative partner to many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT has a global presence with production sites and sales offices in 34 countries. In the 2018/2019 fiscal year, the group generated sales of EUR 2.2 billion (US$ 2.54 billion) with over 16,200 employees. SCHOTT AG has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. This is one of the oldest private and largest science-promoting foundations in Germany. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.
Vice President Marketing and Communication